Wyeth News
Most Popular Wyeth Story
Whistleblowers allege problems with Wyeth's Prevnar
Two former Wyeth workers continue to cause controversy for Wyeth's blockbuster vaccine Prevnar. Wyeth disclosed recently that the workers'Â whistleblower suits accused the company of making false... Read more...
Latest Headlines
- November 18, 2009
- November 12, 2009
- April 9, 2009
- April 2, 2009
- January 8, 2009
- December 3, 2008
- October 27, 2008
- October 9, 2008
- March 6, 2008
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
